1202 SEQUENCE ANALYSIS OF HCV VARIANTS FROM A PHASE IIA TRIAL OF MIRAVIRSEN (MIR), AN OLIGONUCLEOTIDE TARGETING MIR-122, IN TREATMENT NAIVE PATIENTS WITH CHRONIC HCV INFECTION

Autor:	L.J. van Doorn, E. van der Veer, Amy K. Patick, A. Chen, K. Zeh, Michael R. Hodges, Anneke K. Raney
Rok vydání:	2012
Předmět:	Therapy naive Hepatology Oligonucleotide business.industry Sequence analysis MiR-122 PHASE IIA TRIAL Medicine business Virology
Zdroj:	Journal of Hepatology. 56:S476
ISSN:	0168-8278
DOI:	10.1016/s0168-8278(12)61214-8
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::2f40c7b45fc0a3efd67e5c1679c70a63 https://doi.org/10.1016/s0168-8278(12)61214-8 Zobrazit plný text záznamu Full Text from ScienceDirect